Implement and open-source proof-of-concept software tools Collaborate with other researchers of the V-ARRAY5G project... simulation software like CST Microwave Studio, HFSS, or Meep Good oral presentation skills: The candidate...
a PhD on the following topic: Software Engineering and AI for CyberSecurity Carrying out research in the predefined areas... and experience in a number of the following topics AI, machine learning, deep learning Software Engineering (e.g., dynamic...
As a leading European software company, we provide cutting-edge digital solutions to hair and beauty businesses... a comprehensive suite of high-end software tools. From intuitive calendars and client databases to seamless online bookings and point...
Salonkee is a leading salon management software and booking platform solution that revolutionizes the experience... for both salons and their customers across 6 countries in Europe. For salon owners, Salonkee management software provides...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »